VRTX Related Company Press Releases

Jun 18, 2013 08:30 AM Vertex Completes Redemption of Convertible Senior Subordinated Notes

Jun 5, 2013 05:30 PM Vertex Announces Webcast of its Presentation at the Goldman Sachs 34th Annual Global Healthcare Conference

Jun 5, 2013 10:21 AM Vertex Announces Presentation of Data at European Cystic Fibrosis Society Conference

May 30, 2013 08:00 AM Alios BioPharma Initiates Phase 1 Clinical Trial for Respiratory Syncytial Virus (RSV) Infection

May 17, 2013 08:30 AM Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015

May 9, 2013 06:07 PM Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

Apr 30, 2013 04:03 PM Vertex Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C

Apr 24, 2013 08:30 AM Vertex Announces New Data that Showed High Viral Cure Rates with a Total of 12 and 24 Weeks of Telaprevir Combination Treatment Among People with Genotype 1 Hepatitis C Who Have the IL28B CC Genotype

Apr 23, 2013 08:30 AM ALS-2200 (VX-135) Viral Kinetic Study Shows Significant Reduction in HCV RNA in People with Genotype 1 Hepatitis C Virus Infection and Cirrhosis, and in People with Genotypes 2, 3 or 4 HCV Infection